~~<i id='84E55C3768'><strike id='84E55C3768'><tt id='84E55C3768'><pre id='84E55C3768'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

entertainment

focus

author：entertainment 2025-09-03 11:44:44 - browse：148

WASHINGTON — Back in 1980, when the Food and Drug Administration approved the use of lead acetate in hair dyes, little was known about the way skin absorbs toxic chemicals.

The skin — and the scalp in particular — were considered tough barriers to break, and many public health officials believed that even if small amounts of lead got through, or were inhaled, it couldn’t really hurt anyone.

But in science, 37 years is an eon. So a coalition of environmental groups, academics, and consumer advocates is pushing FDA to take lead acetate off the market. It is now permitted as a color additive.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： To spot an incipient stroke, tiny brain probe acts ‘like a microscope’

hotspot

explore

leisure time

knowledge

explore

AlexHogan/STATBOSTON— ThetablessetupneartheentranceoftheBigNightLiveconcertvenuelookedlikeatypicalme

WSS

Bird flu in dairy cattle: New measures to control spread to humans

First Opinion on colorectal cancer screening: letter and response

Free medical tuition alone isn't enough to close gaps in primary care

As H5N1 spreads in cows, experts warn against drinking raw milk

Supreme Court to hear if Covid misinformation is protected speech

Boston hospital trains restaurant workers on naloxone for overdoses

entertainment

focus

hotspot

Walensky prepares to leave CDC — and Congress — behind

Raw milk easy to obtain despite bird flu warning, FDA interstate ban

Affirmative action in medical school literally saved lives

WuXi Biologics beefs up its lobbying operation

Moonlake's readout produced a cash windfall. Risks remain

HHS suspends federal funding for EcoHealth Alliance

Wildfire smoke exposes gaps in outdoor worker protections

Scientists uncover potential path to treating deadly childhood tumor

As demand for Covid shots wanes, Moderna seeks its next success

To spot an incipient stroke, tiny brain probe acts ‘like a microscope’

hotspot

Obesity drug from Roche shows promise in early study

Adam's Biotech Scorecard: PDS Biotech's survival benefit is overstated

Scientists uncover potential path to treating deadly childhood tumor

WuXi Biologics execs register to lobby as Congress comes for the company

Young boy dies in trial for Pfizer Duchenne gene therapy

Oral obesity drug from Viking Therapeutics hits key early target

explore

leisure time

knowledge

explore